ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA
510(k) K200676Ref TMASxx(x)yy(ww)(zzz(z)), TMIFxx(x)yy(ww)(zzz(z)), TMICxx(x)yy(ww)(zzz(z))
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | Number++D800RES010001HF | Date13 Aug 2026 | StatusActive |
| United States | FDA 510(k)SESE 510(k) | NumberK200676 | Date8 Jul 2020 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade Name
- Therapon TranspaPrime
- Model / Reference
- TMASxx(x)yy(ww)(zzz(z)), TMIFxx(x)yy(ww)(zzz(z)), TMICxx(x)yy(ww)(zzz(z))
- Primary DI / UDI-DI
- D800TMASxx(x)yy(ww)(zzz(z))0, D800TMIFxx(x)yy(ww)(zzz(z))0, D800TMICxx(x)yy(ww)(zzz(z))0
- Basic UDI-DI
- ++D800RES010001HF, ++D800RES002001HJ
- Direct Marketing DI
- D800TMIFxx(x)yy(ww)(zzz(z))0D800TMICxx(x)yy(ww)(zzz(z))0
- 510(k) Number
- FDA Product Code
- EBG
- EMDN Code
- Q01020605 Temporary dental prostheses
- Device Class
- Class IIa EUDAMEDClass II 510(k)
- Regulation
- 21 CFR Part 872.3770
- EU market of registration
- Italy
- Advisory Committee
- Dental
- FDA Decision
- SESE Substantially Equivalent
Truth per registry
| Field | EUDAMED | 510(k) |
|---|---|---|
| Device Class | Class IIa | Class II |
Overview
AI-generated summary, 18 Sep 2026
The ABRO 1, Resiton Gingiva, Prime and Therapon Transpa are dental materials classified under Crown and Bridge, Temporary, Resin. ABRO 1 is a resin composite used for fabricating denture teeth, while Resiton Gingiva is designed for creating denture bases. Prime and Therapon Transpa are specialized resins for producing bite splints, orthodontic splints, and occlusal splints to manage bruxism.
These materials are supplied as dental resins and are intended for professional use in dental laboratories or clinics. They are not sterile at time of supply and must be processed according to standard dental fabrication protocols. The devices are regulated under FDA 510(k) clearance (K200676) and MDR, with classification as FDA Class II devices. Storage and handling follow general dental resin guidelines, and their use is restricted to qualified dental professionals.
Other devices from Zirkonzahn GmbH
Questions
AI-generated answers, 18 Sep 2026
Are these materials intended for direct patient application in a clinical setting, or are they meant for fabrication in a dental lab first?
These materials are designed for professional use in dental laboratories or clinics to fabricate dental prosthetics and appliances. ABRO 1 is used for creating denture teeth, Resiton Gingiva for denture bases, and Prime/Therapon Transpa for bite splints, orthodontic splints, and occlusal splints. They are not sterile at time of supply and must be processed according to standard dental fabrication protocols before patient use.
How should these dental resins be stored, and are there any special handling instructions?
Storage and handling of these materials follow general guidelines for dental resins. Since they are not sterile at time of supply, they should be stored in a clean, dry environment, away from direct sunlight and extreme temperatures, to maintain their integrity. Always refer to the manufacturer’s instructions for precise storage conditions and ensure they are kept out of reach of unauthorized personnel.
Can these materials be reused after fabrication, or are they intended for single-use only?
These dental resins are intended for fabrication into dental prosthetics and appliances, which are typically single-use or designed for long-term patient use depending on the application. The materials themselves are not reusable—they are processed into custom devices like denture teeth, bases, or splints, which are patient-specific and not meant for reuse.
What types of dental appliances can Prime and Therapon Transpa be used to create, and how do they differ from ABRO 1 and Resiton Gingiva?
Prime and Therapon Transpa are specialized resins specifically formulated for fabricating bite splints, orthodontic splints, and occlusal splints to manage conditions like bruxism. In contrast, ABRO 1 is used exclusively for fabricating denture teeth, while Resiton Gingiva is designed for creating denture bases. These distinctions allow each material to meet the unique requirements of its intended application.
What regulatory pathways have these materials gone through, and what does that mean for their use in clinical settings?
These materials have undergone FDA 510(k) clearance (K200676) under the Traditional pathway and are classified as Class II devices, indicating they have been reviewed for substantial equivalence to a predicate device. They are also compliant with the EU Medical Device Regulation (MDR). This means they meet established safety and performance standards for dental resins used in crown and bridge, temporary resin applications, and are restricted to use by qualified dental professionals.
Properties
Other properties (12)
- Sterile: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No